SERACARE LIFE SCIENCES, INC.
Fiscal 2009 Director Compensation Program
Set forth below are the terms of compensation for members of the Board of Directors (the “Board”) of
SeraCare Life Sciences, Inc., a Delaware corporation (the “Company”), as well as the terms of compensation for
the various committees of the Board, for the fiscal year beginning October 1, 2008.
The Compensation Committee of the Board is providing for the common stock and options to be granted as
set forth below to members of the Board under the Company’s Amended and Restated 2001 Stock Incentive
Plan (the “2001 Plan”), pursuant to the Compensation Committee’s authority under Section 1.2(b) of the 2001
Plan to grant and determine the terms of awards under the 2001 Plan. The common stock and options set forth
below are intended to be in lieu of any automatic awards under the 2001 Plan during the fiscal year beginning
October 1, 2008.
Compensation for Members of the Board
• All Board members (other than Ms. Vogt) shall receive an annual retainer of $20,000, of which half shall be
paid in cash and half shall be paid in common stock of SeraCare. This annual retainer shall be paid in quarterly
installments in advance. The valuation of the shares shall be based on the closing price of the shares at the end of
the first business (trading) day of the quarter.
• All Board members (other than Ms. Vogt) shall receive a five-year option to purchase 15,000 shares of the
Company’s common stock at an exercise price equal to the closing price of the Company’s common stock on
the date of the grant, such grant to be made at such time as may be determined by the Board. The Option will
have a vesting period of twelve (12) months, which vests quarterly on a pro-rata basis.
• For service as Chairman of the Board of Directors, Mr. Davis will receive additional annual compensation of
$10,000 paid in cash (pro-rated based on the actual period served) to be paid quarterly in advance, and an
additional option grant of